Providence Capital Advisors’s Alterity Therapeutics ATHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-200
| Closed | -$263 | – | 134 |
|
|
2024
Q3 | $263 | Hold |
200
| – | – | ﹤0.01% | 345 |
|
|
2024
Q2 | $362 | Hold |
200
| – | – | ﹤0.01% | 342 |
|
|
2024
Q1 | $414 | Hold |
200
| – | – | ﹤0.01% | 330 |
|
|
2023
Q4 | $498 | Hold |
200
| – | – | ﹤0.01% | 322 |
|
|
2023
Q3 | $496 | Hold |
200
| – | – | ﹤0.01% | 335 |
|
|
2023
Q2 | $558 | Hold |
200
| – | – | ﹤0.01% | 295 |
|
|
2023
Q1 | $555 | Hold |
200
| – | – | ﹤0.01% | 292 |
|
|
2022
Q4 | $696 | Hold |
200
| – | – | ﹤0.01% | 273 |
|
|
2022
Q3 | $1K | Hold |
200
| – | – | ﹤0.01% | 294 |
|
|
2022
Q2 | $1K | Hold |
200
| – | – | ﹤0.01% | 271 |
|
|
2022
Q1 | $2K | Hold |
200
| – | – | ﹤0.01% | 339 |
|
|
2021
Q4 | $1K | Hold |
200
| – | – | ﹤0.01% | 321 |
|
|
2021
Q3 | $3K | Buy |
+200
| New | +$3K | ﹤0.01% | 263 |
|